315 related articles for article (PubMed ID: 15567898)
41. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis.
Bredemeier M; Xavier RM; Capobianco KG; Restelli VG; Rohde LE; Pinotti AF; Pitrez EH; Vieira MV; Fontoura MA; Ludwig DH; Brenol JC
J Rheumatol; 2004 Feb; 31(2):286-94. PubMed ID: 14760798
[TBL] [Abstract][Full Text] [Related]
42. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R; Ferri C; Giuggioli D; Bajocchi G; Dagna L; Bellando-Randone S; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Lepri G; Girelli F; Riccieri V; Zanatta E; Bosello SL; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano AM; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Cipolletta E; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Di Vico C; Gigante A; Pellagrino G; Pigatto E; Lazzaroni MG; Franceschini F; Generali E; Mennillo G; Barsotti S; Mariano GP; Furini F; Vultaggio L; Parisi S; Peroni CL; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Guiducci S; Doria A; Salvarani C; Iannone F; Matucci-Cerinic M;
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36868782
[TBL] [Abstract][Full Text] [Related]
43. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
[TBL] [Abstract][Full Text] [Related]
44. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
[TBL] [Abstract][Full Text] [Related]
45. Simple counting of nailfold capillary density in suspected systemic sclerosis - 9 years' experience.
Wildt M; Hesselstrand R; Akesson A; Scheja A
Scand J Rheumatol; 2007; 36(6):452-7. PubMed ID: 18092267
[TBL] [Abstract][Full Text] [Related]
46. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
47. [Sclerodermic acrosyndromes].
Carpentier PH
Rev Prat; 2002 Nov; 52(17):1891-5. PubMed ID: 12532865
[TBL] [Abstract][Full Text] [Related]
48. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive measurement of skin autofluorescence is increased in patients with systemic sclerosis: an indicator of increased advanced glycation endproducts?
Murray AK; Moore TL; Manning JB; Griffiths CE; Herrick AL
J Rheumatol; 2012 Aug; 39(8):1654-8. PubMed ID: 22753661
[TBL] [Abstract][Full Text] [Related]
50. Variations of neuronal nitric oxide synthase in systemic sclerosis skin.
Ibba-Manneschi L; Niissalo S; Milia AF; Allanore Y; Del Rosso A; Pacini A; Manetti M; Toscano A; Cipriani P; Liakouli V; Giacomelli R; Kahan A; Konttinen YT; Matucci-Cerinic M
Arthritis Rheum; 2006 Jan; 54(1):202-13. PubMed ID: 16385516
[TBL] [Abstract][Full Text] [Related]
51. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
Carulli MT; Handler C; Coghlan JG; Black CM; Denton CP
Ann Rheum Dis; 2008 Jan; 67(1):105-9. PubMed ID: 17604287
[TBL] [Abstract][Full Text] [Related]
52. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
53. Vascular complications of scleroderma.
Guiducci S; Giacomelli R; Cerinic MM
Autoimmun Rev; 2007 Sep; 6(8):520-3. PubMed ID: 17854742
[TBL] [Abstract][Full Text] [Related]
54. Ulnar artery involvement in systemic sclerosis (scleroderma).
Taylor MH; McFadden JA; Bolster MB; Silver RM
J Rheumatol; 2002 Jan; 29(1):102-6. PubMed ID: 11824945
[TBL] [Abstract][Full Text] [Related]
55. Hearing loss in diffuse cutaneous systemic scleroderma.
Monteiro TA; Christmann RB; Bonfá E; Bento RF; Novalo-Goto ES; Vasconcelos LG
Scand J Rheumatol; 2011 Nov; 40(6):467-71. PubMed ID: 21916804
[TBL] [Abstract][Full Text] [Related]
56. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.
Shand L; Lunt M; Nihtyanova S; Hoseini M; Silman A; Black CM; Denton CP
Arthritis Rheum; 2007 Jul; 56(7):2422-31. PubMed ID: 17599771
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary capillary endothelial dysfunction in early systemic sclerosis.
Orfanos SE; Psevdi E; Stratigis N; Langleben D; Catravas JD; Kyriakidis M; Moutsopoulos HM; Roussos C; Vlachoyiannopoulos PG
Arthritis Rheum; 2001 Apr; 44(4):902-11. PubMed ID: 11315930
[TBL] [Abstract][Full Text] [Related]
58. Classification of systemic sclerosis. Visions and reality.
Wollheim FA
Rheumatology (Oxford); 2005 Oct; 44(10):1212-6. PubMed ID: 15870151
[TBL] [Abstract][Full Text] [Related]
59. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients.
Sato LT; Kayser C; Andrade LE
Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777
[TBL] [Abstract][Full Text] [Related]
60. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
